Integra LifeSciences Holdings Corporation
Price Action
Technical Summary
CONSOLIDATINGIntegra LifeSciences Holdings Corporation is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is leading (RS Rating: 90), indicating clear outperformance against the broad market. Earnings growth of 82% provides fundamental context to the price action. However, price is extended 26% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $16.74 | +5.16% | ABOVE |
| 50 SMA | $14.02 | +25.56% | ABOVE |
| 100 SMA | $12.15 | +44.80% | ABOVE |
| 150 SMA | $12.32 | +42.85% | ABOVE |
| 200 SMA | $12.79 | +37.60% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is IART in an uptrend right now?
IART has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is IART overbought or oversold?
IART's RSI (14) is 64. The stock is in neutral territory, neither overbought nor oversold.
Is IART outperforming the market?
IART has a Relative Strength (RS) Rating of 90 out of 99. Yes, IART is a market leader, outperforming 90% of all stocks over the past 12 months.
Where is IART in its 52-week range?
IART is trading at $17.60, which is 96% of its 52-week high ($18.26) and 93% above its 52-week low ($8.70).
How volatile is IART?
IART has a Beta of 2.10 and 52-week volatility of 62%. It's more volatile than the S&P 500 - expect bigger swings.